KYAW MYINT
U.S. Citizen
Department of Computational Biology
Carnegie Mellon University and University of Pittsburgh
**** ****, **** ***** ***., Pittsburgh, PA 15213.
917-***-****. **************@*****.***
RESEARCH INTERESTS
Computational biology, ADME and Toxicity predictions, QSAR and statistical modeling, cheminformatics, structure-based and ligand-based drug design.
HIGHLIGHTS
Computational biologist with dual degrees and interdisciplinary background
Developed several QSAR and ADMET prediction models
Discovered novel ligands for cannabinoid receptor and p62 proteins
Co-inventor of a patent for novel p62 inhibitors
Published several manuscripts in peer-reviewed journals
EDUCATION
Ph.D. in Computational Biology
Expected in June-August, 2012
Joint Computational Biology Ph.D. Program
Carnegie Mellon University and University of Pittsburgh, Pittsburgh, PA
Thesis Title: Virtual Screening, QSAR Methods Development and Experimental Validations for GPCR Cannabinoid Ligand Discovery
Advisor: Professor Xiang-Qun Xie
B.S. in Computer Science (GPA: 3.75/4.0)
2003-2007
Hampden-Sydney College, Hampden-Sydney, Virginia, VA.
B.S. in Biology (GPA: 3.8/4.0)
2003-2007
Hampden-Sydney College, Hampden-Sydney, Virginia, VA.
PROFESSIONAL EXPERIENCE
University of Pittsburgh and Carnegie Mellon University
2007-Present
Graduate Research Assistant
Implemented a novel fragment-based QSAR method and other machine learning hit ranking algorithms to predict bioactivities and ADMET properties of chemical ligands using Matlab and C++ programming tools.
Optimized CB2 lead ligands for better affinity and potency using 3D-QSAR studies.
Performed virtual screening using ligand-based and structure-based approaches for novel GPCR Cannabinoid (CB2) ligand and p62 inhibitor discoveries.
Discovered and patented novel p62 inhibitors important for multiple myeloma.
Performed 3H-radioligand binding assays to validate my predicted hit ligands for affinity/selectivity.
Johnson and Johnson Pharmaceuticals Inc.
June-September, 2011
Polypharmacology Summer Intern
Advisor: Dr. Radu Dobrin
Implemented cheminformatics-based polypharmacology approach to identify off-targets/side-effects.
Constructed drug-target networks, drug-drug networks and analyzed using CytoScape.
Discovered and validated side-effects of some of known drugs and presented final results to the members of the In Silico Immunology (ISI) group.
National Institute of Health
May-August, 2007
Computational Imaging Summer Intern
Advisor: Dr. Bernard Heymann
Analyzed noisy 2D electron microscopy images to improve 3D image reconstruction of particles.
Provided initial insights and data analyses to improve image reconstructions.
Wrote a scientific report and presented a poster at the Summer Internship Program (SIP) Retreat.
Texas A&M University
May-August, 2006
Bioinformatics Summer Researcher
Advisor: Dr. Sing-Hoi Sze
Conducted an independent research on studying local gene rearrangements for certain yeast species.
Wrote a scientific report and presented a poster at the REU Summer Program.
Hampden-Sydney College
May-August, 2005
Computational Chemistry Summer Researcher
Advisor: Professor Paul Mueller
Performed computations to predict activities of Baylis-Hillman catalysts by using GAUSSIAN03
Produced a written scientific report and presented it to the members and faculty of Honors Council.
RESEARCH AND TECHNICAL SKILLS
Computational: QSAR method development, CoMFA, machine learning, structure-based and ligand-based drug design, statistical and mathematical modeling.
Software: Cytoscape, Sybyl Tripos, OpenBabel, VMD, Chemoffice, ChemAxon, Marvin.
Programming Languages: Matlab, C/C++, Python.
Experimental: Mammalian cell culture, radioligand (using radioactive ligands) binding assay.
PUBLICATIONS AND PATENT
A complete list is attached as a separate file. It includes:
1. 3 publications in peer-reviewed journals (2 more manuscripts submitted)
2. 1 patent
3. 6 conference presentations
HONORS AND AWARDS
NIH Predoctoral fellowship (2010-Present)
Patrick Henry Scholarship and Dean’s List-All Semesters (Hampden-Sydney College, 2003-2007)